Merck Aktie
146,10
EUR
-4,90
EUR
-3,25
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| Deutsche Bank AG | 174,00 EUR | +18,25% | 31.01.2025 | |
| JP Morgan Chase & Co. | 190,00 EUR | +29,12% | 20.01.2025 | |
| Goldman Sachs Group Inc. | 185,00 EUR | +25,72% | 09.01.2025 | |
| Bernstein Research | 168,00 EUR | +14,17% | 07.01.2025 | |
| DZ BANK | - | - | 02.12.2024 | |
| UBS AG | 190,00 EUR | +29,12% | 15.11.2024 | |
| Jefferies & Company Inc. | 180,00 EUR | +22,32% | 14.11.2024 | |
| Barclays Capital | 195,00 EUR | +32,52% | 01.08.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 5 | 4 | 0 | 134,95 GBP | +18,96% |
| BASF | 8 | 3 | 0 | 53,84 EUR | - |
| Bayer | 1 | 8 | 0 | 24,12 EUR | - |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 8 | 1 | 2 | 140,88 EUR | +9,17% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | - |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 6 | 1 | 16,49 GBP | - |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 3 | 5 | 2 | 390,44 EUR | +8,99% |
| LANXESS AG | 5 | 2 | 3 | 27,94 EUR | - |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 183,14 EUR | +24,46% |
| Novartis AG | 3 | 5 | 1 | 99,00 CHF | +3,58% |
| Pfizer Inc. | 3 | 3 | 0 | 31,20 USD | +17,65% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Reckitt Benckiser Plc | 4 | 6 | 0 | 54,73 GBP | +2,68% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 2 | 0 | 113,43 EUR | +8,57% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 5 | 2 | 3 | 47,80 GBP | +3,20% |
| WACKER CHEMIE AG | 6 | 2 | 0 | 108,29 EUR | - |